These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2576744)

  • 1. Effect of adafenoxate on different rat brain structures monoamine oxidase activity in vitro.
    Stancheva S; Kunova P
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(1):41-4. PubMed ID: 2576744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of centrophenoxine, piracetam and aniracetam on the monoamine oxidase activity in different brain structures of rats].
    Stancheva SL; Alova LG
    Farmakol Toksikol; 1988; 51(3):16-8. PubMed ID: 3137089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effect of the nootropic agent adafenoxate on the 5-HT1 sites in different rat brain structures.
    Hadjiivanova CI; Stancheva SL
    Gen Pharmacol; 1994 Sep; 25(5):977-9. PubMed ID: 7835647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats).
    Petkov VD; Stancheva SL; Tocuschieva L; Petkov VV
    Gen Pharmacol; 1990; 21(1):71-5. PubMed ID: 2105261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the nootropic agents adafenoxate and meclofenoxate on brain biogenic monoamines in aged rats.
    Stancheva SL; Petkov VD; Petkov VV
    Acta Physiol Pharmacol Bulg; 1988; 14(1):14-21. PubMed ID: 3136616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biogenic monoamine uptake by rat brain synaptosomes during aging. Effects of nootropic drugs.
    Stancheva SL; Alova LG
    Gen Pharmacol; 1994 Sep; 25(5):981-7. PubMed ID: 7835648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes of cyclic AMP phosphodiesterase activity in rat brain regions and a new phosphodiesterase inhibitor--nootropic agent adafenoxate.
    Stancheva SL; Alova LG
    Gen Pharmacol; 1991; 22(5):955-8. PubMed ID: 1662175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the nootropic agents adafenoxate, meclofenoxate and the acetylcholine precursor citicholine on the brain muscarinic receptors (experiments on rats).
    Petkov VD; Popova JS
    Acta Physiol Pharmacol Bulg; 1987; 13(2):3-10. PubMed ID: 3118641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies on the effects of the nootropic drug adafenoxate and of the cerebral vasodilator flunarizine on arterial smooth muscles.
    Todorov S; Petkov V
    Acta Physiol Pharmacol Bulg; 1988; 14(3):10-6. PubMed ID: 3146886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain.
    Fagervall I; Kelder D; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):143-7. PubMed ID: 2460774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
    Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adafenoxate abolishes the amnesia induced by neonatal 6-hydroxydopamine treatment in rats.
    Genkova-Papazova MG; Stancheva SL; Alova LG; Lazarova-Bakarova MB
    Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):267-71. PubMed ID: 8412411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice).
    Petkov VD; Mosharrof AH; Petkov VV
    Acta Physiol Pharmacol Bulg; 1988; 14(1):3-13. PubMed ID: 3136617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VV; Grahovska T; Petkov VD; Konstantinova E
    Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase.
    Palfreyman MG; McDonald IA; Fozard JR; Mely Y; Sleight AJ; Zreika M; Wagner J; Bey P; Lewis PJ
    J Neurochem; 1985 Dec; 45(6):1850-60. PubMed ID: 3840523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase activity by phenylpropanolamine, an anorectic agent.
    Yu PH
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):163-71. PubMed ID: 3961266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.